MeSH D009375 - glandular and epithelial neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009370:Neoplasms by histologic type
0 Companies
0 Drugs
Success rate
D009375:
Glandular and epithelial neoplasms
0 Companies
0 Drugs
Success rate
D000236:Adenoma
D002277:Carcinoma
D018225:Fibroepithelial neoplasms
0 Companies
0 Drugs
Success rate
D018294:Adnexal and skin appendage neoplasms
0 Companies
0 Drugs
Success rate
D018295:Basal cell neoplasms
D018297:And serous mucinous cystic neoplasms
0 Companies
0 Drugs
Success rate
D018299:And medullary lobular ductal neoplasms
0 Companies
0 Drugs
Success rate
D018301:Mesothelial neoplasms
D018302:Neuroepithelial neoplasms
0 Companies
0 Drugs
Success rate
D018307:Squamous cell neoplasms
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
80%8/10
Phase 2
6%1/17
Phase 3
0%0/2
Approved: 0Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use